3D-MXE

buy 3D-MXE online: High Purity Deoxymethoxetamine for Advanced Dissociative Research in 2026

In the dynamic field of dissociative research chemicals, 3D-MXE (Deoxymethoxetamine, also known as DMXE or 3′-methyl-2-oxo-PCE) stands out as a potent arylcyclohexylamine analog of methoxetamine (MXE). This compound has gained significant attention among researchers studying NMDA receptor antagonism, glutamatergic signaling, and altered states of perception. If you’re searching “buy 3D-MXE online,” “3D-MXE for sale,” or “high purity 3D-MXE powder 2026,” our product offers exceptional ≥98% purity in fine powder form, ideal for precise laboratory investigations.

3D-MXE is structurally similar to methoxetamine but features a key modification: the 3-methoxy group is replaced by a methyl group, resulting in a unique pharmacological profile that researchers explore for its dissociative properties and potential differences in duration, potency, and receptor interactions. Sold strictly for research purposes only—not for human consumption—this guide covers 3D-MXE effects, 3D-MXE dosage considerations, research applications, DMXE results from studies, safety notes, and why our 3D-MXE powder is the preferred choice for serious scientific work in 2026.

What Is 3D-MXE? Chemical Profile and Background

3D-MXE, chemically known as 3′-methyl-2-oxo-PCE or Deoxymethoxetamine, belongs to the arylcyclohexylamine family of dissociative research chemicals. It is an analog of methoxetamine (MXE) where the 3-methoxy substituent is substituted with a methyl group, creating a compound with distinct characteristics while retaining the core dissociative framework.

The molecular formula is C15H21NO, with a structure featuring a cyclohexanone ring, ethylamino side chain, and 3-methylphenyl substitution. This modification influences lipophilicity, metabolic stability, and receptor binding, making 3D-MXE a valuable tool for comparative pharmacology. First reported in research markets around 2020–2021, DMXE (3D-MXE) has become a staple in studies of NMDA receptor antagonism and dissociative mechanisms.

High-search terms like “3D-MXE vs MXE” and “3D-MXE compound” highlight its popularity as a modern successor to MXE, offering researchers a compound with potentially altered potency and duration for detailed NMDA and glutamatergic investigations.

Key Benefits of 3D-MXE in Dissociative Research

3D-MXE provides several compelling advantages for laboratory studies:

1. Potent NMDA Receptor Antagonism – High affinity for the dizocilpine (MK-801) site, ideal for modeling dissociative states and glutamatergic inhibition.
2. Exploration of Altered Perception – Valuable for research into changes in sensory processing, time/space distortion, and detachment phenomena.
3. Neuroplasticity Studies – Supports investigations into synaptic plasticity and glutamate signaling modulation.
4. Comparative Pharmacodynamics – Allows side-by-side analysis with MXE, ketamine, and 2′-Oxo-PCE analogs.
5. Metabolic Stability – Structural modification may offer improved half-life in certain models compared to parent compounds.

3D-MXE effects in research models include dissociation, perceptual alterations, and potential neuroprotective mechanisms—making it a key tool for studying altered states of consciousness and central nervous system function.

Recommended 3D-MXE Dosage and Research Protocols

3D-MXE dosage in controlled studies varies widely depending on the research objective, but precision is essential due to potency:

• Low-Dose Studies: 5–15mg for baseline receptor binding and mild effects.
• Moderate Research: 20–40mg for stronger dissociative profiling.
• Higher-Dose Investigations: 50mg+ for intense perceptual models (with extreme caution).

3D-MXE cycle protocols typically involve single-dose or short-term administration in vitro/in vivo models, with washout periods to assess recovery. Researchers often use DMXE in solution form (dissolved in ethanol or saline) for accurate delivery.

Queries for “3D-MXE dosage” emphasize starting low and scaling based on receptor occupancy data. Always document conditions for reproducibility in dissociative research.

Research Applications and Insights for 3D-MXE

3D-MXE is primarily used for:

• NMDA receptor antagonism studies
• Dissociative effect profile analysis
• Neuroprotective mechanisms research
• Comparative pharmacodynamics with MXE and ketamine
• Altered states of perception in behavioral models

DMXE results from early studies suggest potent dissociative activity, with potential differences in duration and intensity compared to MXE. Researchers note its value in investigating glutamatergic pathways and synaptic plasticity.

Safety Considerations and 3D-MXE Side Effects in Research

3D-MXE side effects in controlled models may include altered perception, dissociation, and cardiovascular changes. As a potent NMDA antagonist, it requires strict safety protocols:

• Full PPE and fume hood use
• Proper ventilation and waste disposal
• Monitoring for respiratory or neurological effects in vivo

3D-MXE research stresses controlled environments and ethical guidelines—no human use.

Why Choose Our 3D-MXE Powder

For “buy 3D-MXE online” or “3D-MXE for sale,” our product excels:

• 98%+ Purity: Third-party tested with COAs
• Fine Powder Form: Easy weighing and dissolution
• Discreet Global Shipping: Secure, tracked delivery
• Research-Grade Quality: Ideal for DMXE research applications
• Bulk Availability: Competitive pricing for labs

Leading choice for high-quality 3D-MXE powder in 2026.

Legal Status of 3D-MXE in 2026

3D-MXE (DMXE) is unscheduled in many regions for research but may fall under analog acts if misused. Sold exclusively for laboratory purposes—verify “3D-MXE legal status 2026” locally.

Frequently Asked Questions About 3D-MXE

• What is 3D-MXE used for? NMDA antagonism, dissociative, and perception studies.
• 3D-MXE dosage in research? 5–50mg depending on protocol.
• 3D-MXE effects? Dissociation, altered perception, sensory changes.
• 3D-MXE vs MXE? Similar but with methyl substitution for unique profile.

Conclusion: Advance Dissociative Research with 3D-MXE

In 2026, 3D-MXE (Deoxymethoxetamine) remains a powerful tool for exploring NMDA receptor dynamics and dissociative pharmacology. Its high purity and precise 3D-MXE dosage make it ideal for cutting-edge studies.

Order your 3D-MXE powder today—strictly for research use only. Elevate your investigations with trusted quality.